| # | Drug | Count |
|---|---|---|
| 0 | IVOSIDENIB | 4 |
| 1 | LENALIDOMIDE | 4 |
| 2 | VENETOCLAX | 3 |
| 3 | CARBOPLATIN | 2 |
| 4 | CILTACABTAGENE AUTOLEUCEL | 2 |
| 5 | MELPHALAN | 2 |
| 6 | MELPHALAN HYDROCHLORIDE | 2 |
| 7 | PEMBROLIZUMAB | 2 |
| 8 | POMALIDOMIDE | 2 |
| 9 | TEMOZOLOMIDE | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IVOSIDENIB | 4 | 0.0018 |
| 1 | CEDAZURIDINE AND DECITABINE | 1 | 0.0010 |
| 2 | LOMUSTINE | 1 | 0.0004 |
| 3 | CILTACABTAGENE AUTOLEUCEL | 2 | 0.0003 |
| 4 | STERILE WATER FOR INJECTION | 1 | 0.0002 |
| 5 | TEMOZOLOMIDE | 2 | 0.0001 |
| 6 | MELPHALAN HYDROCHLORIDE | 2 | 0.0001 |
| 7 | VENETOCLAX | 3 | 0.0000 |
| 8 | AZACITIDINE | 1 | 0.0000 |
| 9 | PEMETREXED DISODIUM | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Isocitrate Dehydrogenase 1 Inhibitor [EPC] | 4 | 0.0018 |
| 1 | BCL-2 Inhibitor [EPC] | 3 | 0.0000 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 2 | 0.0000 |
| 3 | Alkylating Drug [EPC] | 3 | 0.0000 |
| 4 | Thalidomide Analog [EPC] | 4 | 0.0000 |
| 5 | Platinum-based Drug [EPC] | 2 | 0.0000 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 2 | 0.0000 |
| 7 | Janus Kinase Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Microtubule Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 1 | 0.0000 |